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Lenz-Majewski syndrome (LMS) is a rare disease characterized by
complex craniofacial, dental, cutaneous, and limb abnormalities
combined with intellectual disability. Mutations in the PTDSS1
gene coding one of the phosphatidylserine (PS) synthase enzymes,
PSS1, were described as causative in LMS patients. Such mutations
render PSS1 insensitive to feedback inhibition by PS levels. Here
we show that expression of mutant PSS1 enzymes decreased
phosphatidylinositol 4-phosphate (PI4P) levels both in the Golgi
and the plasma membrane (PM) by activating the Sac1 phospha-
tase and altered PI4P cycling at the PM. Conversely, inhibitors of
PI4KA, the enzyme that makes PI4P in the PM, blocked PS synthesis
and reduced PS levels by 50% in normal cells. However, mutant
PSS1 enzymes alleviated the PI4P dependence of PS synthesis.
Oxysterol-binding protein–related protein 8, which was recently
identified as a PI4P-PS exchanger between the ER and PM, showed
PI4P-dependent membrane association that was significantly de-
creased by expression of PSS1 mutant enzymes. Our studies reveal
that PS synthesis is tightly coupled to PI4P-dependent PS transport
from the ER. Consequently, PSS1 mutations not only affect cellular
PS levels and distribution but also lead to a more complex imbal-
ance in lipid homeostasis by disturbing PI4P metabolism.
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lipid transfer
Maintenance of the unique lipid composition of differenteukaryotic cell membranes requires a concerted regulation
of lipid synthesis and transport via vesicular trafficking and non-
vesicular lipid transfer (1–3). Most lipids in the cell are synthesized
in the endoplasmic reticulum (ER) or taken up from the outside
for degradation and reutilization via the endo-lysosomal system.
Lipid synthesis is often under strict feedback control, and there-
fore transport of lipids away from the site of synthesis is a key
regulator of lipid synthesis. The importance of such feedback
control is highlighted by the disease Lenz-Majewski syndrome
(LMS) (4). LMS is characterized by multiple skeletal dysplasia-
dysostosis, with characteristic craniofacial and limb abnormalities
combined with intellectual disabilities (5). Recent studies have
identified mutations in the PTDSS1 gene in LMS patients and
showed that these mutations render the enzyme PSS1 resistant to
feedback inhibition by phosphatidylserine (PS) (6).
Recent studies have shown that directional PS transport be-
tween the ER and plasma membrane (PM) can be driven by the
PI4P gradient formed between the two membranes (7, 8). This
gradient is set up by the actions of PI4KA, one of four phos-
phatidylinositol 4-kinases (PI4Ks), which functions in the PM (9)
and the PI4P phosphatase, Sac1, located in the ER and the Golgi
(10). While studying the role of phosphoinositides in the control
of lipid metabolism, we found that uncontrolled PS production
had an impact on lipid homeostasis by affecting phosphatidyl-
inositol 4-phosphate (PI4P) cycling between the PM and the ER.
Results and Discussion
PI4KA Inhibitors Inhibit PS Synthesis. These studies were initiated
to test our hypothesis that a PI4P gradient between the PM and
the ER may be involved in the transport of specific lipids out of
the ER (11) (Fig. 1F). To determine whether PM PI4P pro-
duction has any bearing on the level of any of the phospholipid
classes, we performed lipidomic analysis of HEK293 cells treated
for 30 h with the PI4KA specific inhibitor A1 (12). We found
that the cellular level of PS was consistently decreased by about
50% in cells treated with A1 compared with controls (Fig. 1A).
This effect was specific in that inhibition of PI4KB, another PI4K
that works primarily at the Golgi, had no effect on the levels of
the major phospholipids (Fig. 1A). The reduction in PS mass by
A1 and other PI4KA inhibitors was caused by decreased syn-
thesis as shown by a reduced [3H]serine incorporation into PS
in intact HEK293 cells (Fig. 1 B and C). The effectiveness of
inhibitors on PS synthesis showed good correlation with their in-
hibitory potencies against PI4KA (Fig. 1C). Importantly, A1 did
not affect [3H]serine uptake (Fig. 1D) so the inhibitory effect was
truly on PS synthesis.
Effect of PI4KA Inhibitors on PS Synthesis Is Indirect. It has been
shown previously that PS synthesis is under strong product in-
hibition (13). Therefore, we reasoned that interfering with
PI4KA function might have affected PS synthesis indirectly by
blocking the transport of PS from the ER. PS is synthesized by
two enzymes, PSS1 and PSS2, by head-group exchange from
phosphatidylcholine (PC) and phosphatidylethanolamine (PE),
respectively (Fig. 1E). If inhibition of PS synthesis by PI4KA
inhibition were related to a transport defect, one would expect
that PSS1 enzymatic activity in membrane preparations would
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not be sensitive to PI4K inhibition. Fig. 1J shows that A1 was
indeed without effect on PS synthase activity of membrane
preparations obtained from cells expressing the PSS1 enzyme. It
is important to emphasize that the PI4KA inhibitor A1 inhibited
PS synthesis only in intact cells and not the PSS1 enzyme itself.
Next we tested the effects of A1 in cells expressing mutant PSS1
enzymes described in LMS (6) that are insensitive to PS-mediated
negative feedback. If the A1 effect were indeed due to ER re-
tention of PS, such mutant enzymes should be resistant to PI4KA
inhibition even in the intact cells. As shown in Fig. 1H, expression
of mutant PSS1 enzymes (L265P, P269S, and Q353R) elicited a
very robust increase in PS synthesis in intact cells, significantly
higher than the wild-type protein. Importantly, A1 treatment only
slightly decreased PS synthesis in such cells (Fig. 1I); the small
effect was attributed to inhibition of the endogenous enzyme.
Notably, expression of PSS2 enzyme increased the synthesis of a
faster running PS species, which was also less inhibited by the
PI4K inhibitor (Fig. 1 H and I).
PS Accumulates in the ER in Cells Expressing PSS1 Mutant Enzymes.
Next we examined the effects of the PSS1 mutations on the
distribution of PS using the LacC2 PS reporter (14) (Fig. 2A). It
has been well documented that PS is found mostly in the PM and
some endosomes as visualized by the LacC2 reporter (14) de-
spite the fact that PS is synthesized in the ER. As shown in Fig.
2B, even when we overexpressed PSS1 or -2, there was no sign
that PS was present in the ER. In contrast, overexpression of the
PSS1 mutant enzymes has profoundly changed PS distribution,
which now shows clearly detectable ER localization (Fig. 2 C–E).
Some mutants, namely P269S, also generated large vesicles
positive for PS (Fig. 2D). These results suggested that PS is very
efficiently transported out of the ER but appears in the ER when
the PSS1 enzyme loses its product inhibition. These results also
supported the notion that PS synthesis is very tightly coupled to
PS transport out of the ER. If PI4KA-Sac1–mediated cycling is
important for PS transport between the ER and the PM as shown
recently (7, 8), then inhibition of PI4KA is expected to impact PS
levels in the PM. To test if this was indeed the case, we used a
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Fig. 1. Plasma membrane PI4P production is critical for PS synthesis. (A) Lipidomic analysis of HEK293-AT1 cells treated with PI4K inhibitors for 30 h. Note the
significant reduction in PS levels by the PI4KA inhibitor A1 (100 nM) but not by the PI4KB inhibitor PIK93 (300 nM). Means ± SEM from three independent
experiments performed in duplicates (*P < 0.05 by paired t test). (B) Representative TLC plate showing incorporation of L-[3H]serine into PS by HEK293-AT1
cells in 3 h in the presence and absence of the PI4KA inhibitor A1. The arrows indicate a faster and slower migrating PS species. (C) Quantitation of PS labeling
in the presence of various inhibitors (A1, F1, C1, and PIK93 are inhibitors of PI4KA and PI4KB, respectively). TLC spots were scraped and measured by scin-
tillation spectrometry. Values were normalized to DMSO-treated controls. Average values of two experiments are shown. The range (<10%) has been omitted
for clarity. (D) L-[3H]serine uptake is not affected by A1 treatment. Cell-associated radioactivity was measured at the indicated times in two experiments
(means ± range). (E) Schematics of the enzymology and sites of PS synthesis. (F) Cartoon depicting the ER-PM PI4P cycling and its relationship to PS transport.
(G) Cartoon showing the location of the LMS mutations in PSS1 enzyme. (H) Effect of PSS1-GFP wild-type or mutant proteins on L-[3H]serine incorporation into
PS shown in a representative TLC. The migration difference is due to the uneven run on this particular TLC. (I) The effects of A1 on L-[3H]serine incorporation in
cells expressing the wild-type or various mutant PSS1 enzymes fused to GFP. (Upper) A representative TLC plate. (Lower) The quantification from two ex-
periments with the range of the two determinations. Values were normalized to GFP-transfected controls. (J) PSS1 activity measurements in membranes
prepared from COS-7 cells transfected with vector or PSS1-GFP wild-type enzyme. Note the lack of effect of the PI4KA inhibitor A1 (100 nM) in these
membrane assays (means ± SEM from three membrane preparations assayed in duplicate).
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recently developed bioluminescence resonance energy transfer
(BRET) approach to monitor the level of PS in the PM using the
LacC2 reporter (15) (Fig. 3A). A1 treatment induced a small but
reproducible decrease in PM PS levels (Fig. 3B) consistent with a
decreased transport from the ER (note that the BRET signal
increases with time in DMSO-treated controls). Given the high
level of PS in the membrane, it may require a longer time to
achieve a more substantial decrease.
PS Overproduction Increases Sac1 Activity and Reduces PI4P Levels.
Having established the mechanism by which PI4KA controls PS
synthesis, we wanted to know how PS overproduction affects
PI4P metabolism. It has been described that PS stimulates the
enzymatic activity of recombinant Sac1, the enzyme that de-
phosphorylates PI4P in the ER (16). Similarly, yeast strains
defective in PS synthesis show decreased Sac1 activity (16).
Therefore, we measured Sac1 activity in crude membranes pre-
pared from cells overexpressing PSS1 mutant enzymes and
compared them to vector-transfected controls. Fig. 3C shows
that expression of PSS1-P269S has significantly increased the
Sac1 activity of membranes. We then measured PI4P levels
specifically in various compartments using immunostaining
techniques (17) in HEK293 cells expressing the mutant PSS1-
P269S enzyme. Quantification of the immunostained images
showed significantly reduced levels of PI4P both in the Golgi and
the PM in cells expressing the mutant PSS1-GFP relative to
those expressing GFP only (Fig. 3 D–G). This was consistent with
the increased Sac1 activity reducing the levels of PI4P in mem-
branes from where PI4P is either delivered to the ER or where
Sac1 can directly access PI4P.
The PS-Transport Protein ORP8 Is Affected by PM PI4P and ER PS
Production. Recent studies identified the oxysterol-binding pro-
tein-related proteins ORP8 and ORP5 (and OSH6 in yeast) as
capable of transporting PS from the ER to the PM in exchange for
PI4P moving in the other direction (7, 8). Therefore, we in-
vestigated the effects of overproduction of PS by PSS1-P269S on
this lipid exchange process. First, we examined whether knocking
down these ORP proteins affected PI4P in the PM (PI4Ppm). If
these ORP proteins deliver PI4P from the PM to the Sac1 phos-
phatase in the ER, their depletion may affect the rate of PI4P
disappearance from the PM after inhibition of PI4KA. We fol-
lowed the kinetics of PI4Ppm changes after inhibition of PI4KA
using the BRET approach (15) (Fig. 4 A and B). As expected, A1
treatment led to a steady decline of PI4Ppm. Knockdown of ORP5
had only a minor effect on either the resting BRET signal or the
kinetics of decline after A1 treatment. In contrast, ORP8 knock-
down increased the basal BRET signal and slowed down the
PI4Ppm decrease. Combined knockdown of both ORP proteins
had the largest effect, increasing the resting BRET signal and
slowing the decay (Fig. 4C). These results were consistent with the
recent data of Chung et al. (7) and suggested a redundant and
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Fig. 2. Cellular distribution of PS and the PSS1 en-
zyme in HEK293-AT1 cells. (A) PS distribution was
assessed by the PS-binding C2 domain of lactadherin
fused to mCherry, and the PSS1 enzyme was tagged
with GFP at its C terminus. (B) Wild-type PSS1-GFP
overexpression does not affect the localization of PS,
which is detected primarily in the PM and in endo-
somal compartments by confocal microscopy of live
cells. There is no colocalization between the two sig-
nals except in a small pericentriolar area as indicated
by the line intensity histogram shown on the Right.
(C–E) Expression of LMS mutant PSS1 enzymes causes
accumulation of PS in the ER. The line-intensity histo-
grams show a good correlation between the localiza-
tions of the PS and PSS1 mutant enzymes. Although
many cells shown here are multinucleated, the frac-
tion of multinucleated cells was not notably changed
by expression of PSS1 mutant enzymes.
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complementary role of these ORP5 and ORP8 proteins in de-
livering PI4P to the ER for the Sac1 phosphatase. However, these
data also suggested that PI4P is removed from the PM by addi-
tional mechanism(s) either by other PI4P transfer proteins or by
the resting phospholipase C activity of the PM.
Overexpression of PSS1-P269S decreased the basal BRET
signal and significantly slowed down the rate of PI4Ppm decrease
(Fig. 4D). PSS1 wild-type overexpression did not have a similar
effect: in fact, it slightly elevated the BRET signal and, accord-
ingly, delayed the PI4Ppm decline (Fig. 4D). As expected, Sac1
overexpression increased PI4Ppm decline after PI4KA inhibition,
suggesting that it is the Sac1 activity and not the access to PI4P,
which limits the PI4P clearing process. These data suggested that
the PI4P transfer process was reduced in cells overproducing PS
and that it was not a simple consequence of Sac1 activation. To
determine if PS overproduction down-regulated ORP5 or ORP8,
we measured the levels of both ORP5 and ORP8 mRNAs by
qPCR in cells expressing wild-type or mutant PSS1 enzymes.
This analysis showed no significant reductions in the mRNA
level (Fig. 4E). However, the number of contact sites between
the PM and ORP8 was significantly reduced in cells expressing
the mutant PSS1 enzyme relative to the wild type (Fig. 4F).
ORP8 and ORP5 contacts the PM via their PH domains through
interaction with PI4P (7). In agreement with those findings,
acute A1 treatment eliminated the ER-PM contacts of ORP8 as
judged by total internal reflection fluorescence (TIRF) micros-
copy (Fig. 4G). Therefore, the reduced level of PI4P in the PM
observed after PSS1-P269S overexpression could explain the
reduced number of ORP8 PM contacts. These findings together
strongly suggested that cells have implemented a protective mech-
anism to spare PI4P in the PM against a massively overproduced PS
by limiting the delivery of PI4P from the PM to the ER for
the Sac1-phosphatase.
In summary, the present studies have revealed a tight re-
lationship between PS metabolism and PI4P turnover at ER-PM
contact sites. Critical elements of this regulatory loop are the
product inhibition of the PSS1 enzyme by PS, the activation of
Sac1 by PS, and the PI4P-dependent transport of PS from the
ER. Mutations that render the PSS1 enzyme resistant to product
inhibition derail this process, putting a strain on PI4P turnover at
the ER-PM junctions. The LMS causing mutations are located in
the predicted ER luminal side of the PSS1 enzyme, suggesting
that PS exerts its inhibitory effect on the luminal side. However,
PS clearly accumulates on the cytoplasmic surface of the ER
when mutant PSS1 enzymes are expressed and that is where it
can activate the Sac1 enzyme. This raises the question of the role
of PS flippases in connecting these metabolic control steps (18).
Although overproduced PS activates the Sac1 enzyme, it nega-
tively affects ORP8/5-mediated PI4P delivery to the ER, which
likely serves as a protective mechanism to spare the PM phos-
phoinositide pools. Because Sac1 also controls PI4P levels in the
Golgi, PS overproduction also affects Golgi PI4P pools and
hence is expected to impact the transport of cholesterol (19, 20),
ceramide (21), and complex sphingolipids (22). A tight re-
lationship between Sac1-mediated PI4P cycle and PS synthesis
has been described in yeast (23). These studies suggest evolu-
tionary conservation of the tight relationship between PS and
PI4P metabolism. Our studies highlight the complexity of lipid
changes that are caused by a single mutation that renders the
PSS1 enzyme resistant to product inhibition, offering deeper
insight into the complex pathology of the LMS disease.
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Fig. 3. PI4KA inhibition reduces PM PS levels, and
PS overproduction affects PI4P levels. (A) Sche-
matics of the principles of quantification of PM-
localized PS by BRET analysis. The PS-binding LacC2
domain fused to S-luciferase excites the PM-tar-
geted Venus in a proximity-dependent manner in
the presence of coelenterazine. Reduced PS levels
would release some of the LacC2 from the mem-
brane, decreasing the energy transfer to Venus.
See SI Materials and Methods for more details.
(B) Fractional BRET signal changes as a function of
time in cells treated with A1 (30 nM) (red) or DMSO
(black). The rapid dip in the signal is an artifact
due to the removal of the plate at the beginning
of the recording when the inhibitors are added.
Ionomycin (10 μM) was added at the end of the
incubations to induce PS externalization that decreases
the level of PS in the cytoplasmic leaflet of the PM.
A1 treatment caused a slow decrease in the BRET
signal relative to the DMSO-treated control. Grand
means ± SEM are shown from three independent
experiments performed in triplicates and normal-
ized to the initial BRET value of control cells. (C )
Overexpression of LMS mutant PSS1(P269S)-GFP
increases the Sac1 activity of isolated crude mem-
branes. Overexpression of GFP-Sac1 was used as a
positive control. Means ± SEM are shown from five
independent membrane preparations. Differences were statistically significant between control and PSS1(P269S) (P < 0.05) and between control and Sac1
(P < 0.001) using a paired t test. (D) Golgi PI4P levels are decreased in cells expressing PSS1(P269S)-GFP as assessed by immunostaining for PI4P. The Golgi
area was identified by gm130 staining, and this mask was used to determine PI4P-staining intensity. Green arrows point to cells that express either GFP
(Upper rows) or PSS1(P269S)-GFP (Lower rows). (E ) Quantitation of a large number of cells (69–123) recorded in several microscopy fields in two separate
experiments are shown. Average pixel intensities were measured in individual cells over the gm130 mask and normalized to the values obtained in cells
that showed no GFP signal in the GFP-transfected sample. Significant difference (P < 0.0001, unpaired t test) was found between the control and
PSS1(P269S)-GFP–expressing cells but not between control and GFP-expressing cells (P = 0.1094). (F ) PM PI4P levels are decreased in cells expressing
PSS1(P269S)-GFP or treated with A1 (1 h, 100 nM) as assessed by immunostaining for PI4P in the PM. Green arrows point to cells that express either GFP
(Upper rows) or PSS1(P269S)-GFP (Lower rows). (G) Quantitation of a large number of cells (68–84) recorded in several microscopy fields in two separate
experiments. Average pixel intensities were measured in individual cells over the phalloidin mask and normalized to the cells expressing GFP only. The
difference between control and PSS1(P269S)-GFP–expressing or A1-treated cells was statistically significant (P < 0.0001 in both cases, unpaired t test).
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Materials and Methods
Materials and DNA Constructs. All materials and DNA constructs are listed in SI
Materials and Methods. Primers used for cloning of DNA constructs are listed
in Table S1.
Cell Culture and Transfection. The HEK293-AT1 cells, a line that stably ex-
presses the rat AT1a angiotensin receptor, have been described previously
(24). HEK293-AT1 and COS-7 cells were grown in Dulbecco’s Modified Eagle
Medium (DMEM-high glucose) containing 10% (vol/vol) FBS and 1% peni-
cillin–streptomycin. For the metabolic labeling experiments, cells were
seeded in 12-well plates (300,000 cells/well) and transfected with 0.3 μg
DNA/well with Effectene Transfection Reagent (Qiagen). For live-cell imag-
ing, cells were plated on glass coverslips, which were precoated with poly-L-
lysine solution (Sigma P8920) in six-well plates (500,000 cells/well). A total of
0.2 μg of DNA/well was used for six-well transfection with Effectene Trans-
fection Reagent. For the Sac1 phosphatase activity assay, COS-7 cells were
plated in 10-cm tissue culture dishes (1,000,000 cells/well) and transfected
with 2 μg DNA/dish using the Effectene Transfection Reagent.
Lipidomic Analysis. Glycerophospholipids from pellets of HEK293-AT1 cells
treated with different inhibitors were extracted using a modified Bligh and
Dyer procedure (25). Briefly, each pellet was homogenized in 800 μL of ice-
cold 0.1 N HCl:CH3OH(1:1) and extracted and analyzed as detailed in SI
Materials and Methods.
Analysis of L-[3H]Serine–Labeled Lipids. HEK293-AT1 cells were preincubated
for 50 min with a modified Krebs–Ringer buffer (120 mM NaCl, 4.7 mM KCl,
1.2 mM CaCl2, 0.7 mM MgSO4, 10 mM glucose, and 10 mM Na–Hepes,
pH 7.4). Cells were treated with the indicated concentrations of PI4K inhibitors
for 10 min followed by labeling with L-[3H]serine (10 μCi/mL) for 3 h at 37 °C.
Labeling was terminated by adding ice-cold perchloric acid [5% (vol/vol) final].
Cells were kept on ice for 30 min, scraped by pipette tips, collected in poly-
propylene tubes, and centrifuged. The pellets were subjected to lipid extrac-
tion and lipids were analyzed by TLC essentially as described previously (26).
TLC plates were sprayed with EN3HANCE Spray (Perkin-Elmer) for autoradi-
ography. For the quantitative analysis spots were scraped from the TLC plates,
and the radioactivity was quantified by scintillation counter. In a few experi-
ments extracted lipids were directly subjected to scintillation spectrometry as
the major radioactive species was PS. For measurement of serine uptake, cells
were seeded and treated with inhibitors as described above and labeled
with L-[3H]serine (2 μCi/mL) for 30 min in 0.5 mL/well of modified Krebs–Ringer
buffer. Labeling was terminated by adding 250 mM L-Ser–containing Krebs–Ringer
buffer (0.1 mL) on ice. Cells were washed with 50 mM L-Ser–containing Krebs–
Ringer buffer (3 × 1 mL). Cells were then lysed with RIPA buffer [1% Nonidet P-40
(vol/vol), 0.5% Na–deoxycholate (wt/vol), 0.1% SDS (wt/vol), 150 mM NaCl, 50 mM
Tris·HCl, pH 7.5] in 0.2 mL/well and subjected to scintillation spectrometry.
Where cells were transfected, these procedures were performed 48 h
after transfection.
Immunocytochemistry. For immunostaining, cells were plated on glass cov-
erslips and transfected with the indicated DNAs for 48 h. For A1 treatment
(100 nM, 1 h) cells were treated in serum-free DMEM before the staining
procedure. Cells were washed with PBS and subjected to the fixation and
staining protocol described for optimal PI4P staining in PM or Golgi as de-
scribed by Hammond et al. (17) with slight modifications as detailed SI
Materials and Methods.
Sac1 Phosphatase Assay. COS-7 cells were seeded on 10-cm culture dishes and
transfected with plasmid DNAs encoding GFP, PSS1(P269S)-GFP, or GFP-Sac1.
After 48 h, cells were washed with the modified Krebs–Ringer buffer and
lysed with 2 mL of reaction buffer (200 mM sodium acetate, 50 mM Pipes,
pH 6.8, and 20 μg/mL porcine gelatin) and broken up by passing through a
25-gauge syringe needle 10 times. After centrifugation at 1,000 × g at 4 °C
for 10 min, the supernatant was subjected to ultracentrifugation at 100,000 × g
at 4 °C for 1 h. The pellet was resuspended in a 200-μL reaction buffer, and the
protein concentration was measured by BCA assay. Lysates (6–16 μg) were mixed
with a reaction buffer of 20 μL final volume for the dephosphorylation reaction.
PI4P dissolved in reaction buffer was added as substrate to a final concentration
of 100 μM. Reactions were run at RT for 30 min and terminated by 20 μL of
100mMN-ethylmaleimide. Samples were centrifuged at 14,000 ×g at 4 °C for 15
min in a microcentrifuge and the phosphate content of the supernatant was
analyzed by a malachite green assay kit (Echelon). The free phosphate amount
was calculated based on a standard curve after absorbance measurement at
620 nm.
PSS1 Base-Exchange Assay. Control vector or PSS1-GFP construct was trans-
fected into COS-7 cells using Lipofectamine 2000. After 1 d of transfection,
cells in six-well dishes were washed and scraped into 0.2 mL of 50 mM Hepes
(pH 7.5) and 5 mM CaCl2 and ruptured by freezing and thawing three times.
P4M-2x
Luc L10-Venus
plasma membrane
PI4P
PI4PPI
PIPI4P
PI4KA
Sac1
ORP8/5
PS
60
0 10 20 30 40 50 60 70 80
0.80
0.85
0.90
0.95
1.00
1.05
time (min)
control 
PSS1wt
Sac1
PSS1P269S
PSS1
PC
PS
10 20 30 40 50 60 70 80 90 100
0.8
0.9
1.0
1.1
time (min)
control 
ORP5-kdown
ORP8-kdown
ORP5+8-kdown
P
M
-P
I4
P 
(n
or
m
al
iz
ed
 B
R
E
T)
P
M
-P
I4
P 
(n
or
m
al
iz
ed
 B
R
E
T)
coelenterazine
+ ATP
G
FP
-O
R
P
8L
 p
un
ct
a/
ar
ea
(n
or
m
al
iz
ed
 to
 P
S
S
1w
t)
A1 A1 
15 min A1 before A1 
PS
S1
wt
PS
S1
(P
26
9S
)
0.0
0.5
1.0
1.5
2.0
2.5
ve
cto
r
PS
S1
wt
PS
S1
(P
26
9S
)
0.0
0.5
1.0
1.5
ve
cto
r
PS
S1
wt
PS
S1
(P
26
9S
)
O
R
P 
m
R
N
A
(n
or
m
al
iz
ed
 to
 v
ec
to
r c
tr)
ORP5 ORP8
ORP8 
PM
ER
PH
ORD
BA
DC
FE G
Fig. 4. Control of PI4P transfer between the PM and
the ER by ORP5 and ORP8 proteins and by PS over-
production. (A) Schematics of BRET analysis of PM
PI4P. Here a tandem P4M domain of Legionella
pneumophila (P4M-2x) was fused to the Luciferase to
monitor PM PI4P levels. (B) Cartoon depicting the
model of the PI4P-PS exchange process between
the PM and the ER by the ORP5 and ORP8 proteins.
The PH domain of these proteins binds PI4P at the PM,
and their C-terminal transmembrane domains anchor
the protein to the ER (7). (C) BRET analysis of PM PI4P
changes after A1 (30 nM) treatment in HEK293-AT1
cells treated with siRNAs for ORP5, ORP8, or both.
Grand means ± SEM is shown from three independent
experiments performed in triplicates and normalized
to the first point after addition of the inhibitor in
control siRNA-treated cells. (D) Similar experiment
shown for changes in PM PI4P in cells overexpressing
mCherry-tagged versions of PSS1 wild type, P269S
mutant, or Sac1. Grand means ± SEM is shown from
three independent experiments performed in tripli-
cates and normalized to the first point before addition
of the inhibitor in the control cells. The rapid drop in
the BRET signal is an artifact caused by the removal of
the plate for stimulation. (E) Quantitative PCR of ORP5
and ORP8 proteins in cells expressing wild-type or
P269S mutant PSS1-GFP. Means and whiskers are
shown from five independent knockdown experi-
ments (ORP5: PSS1wt vs. vector P = 0.051; PSS1P269S
vs. vector P = 0.309; ORP8: PSS1wt vs. vector P = 0.023; PSS1P269S vs. vector P = 0.089, unpaired t test) (F) Quantification of the number of GFP-ORP8 puncta per
foot-print area in TIRF analysis. Means and whiskers are shown from 67 and 133 cells expressing the wild-type or mutant PSS1-mCherry enzyme, respectively.
Values were normalized to the average of the group expressing the wild-type enzyme (P < 0.0001, unpaired t test). (G) Representative TIRF image of a cell
expressing GFP-ORP8 before and after treatment with 100 nM A1. Note the disappearance of the ORP8 puncta after A1 treatment.
4318 | www.pnas.org/cgi/doi/10.1073/pnas.1525719113 Sohn et al.
The crude membranes were centrifuged in a bench-top centrifuge at 13,000 × g
for 10 min. The assay was performed essentially as described (27). Briefly,
the reaction mixture contained 50 mM Hepes (pH 7.5), 5 mM CaCl2, 0.1%
Triton X-100, 0.4 mM phosphatidylcholine (Avanti Polar lipids), 0.01 mM
L-Ser (Sigma), 20 μCi L-[3H]serine, and an aliquot of the crude membrane, all
in a total volume of 0.1 mL. After 10 min of incubation at 37 °C, the reaction
was stopped by adding of 0.35 mL of acidic methanol (0.1 N HCl), followed
by 0.5 mL of chloroform and 0.5 mL of 1 M MgCl2. After vortexing, two
phases were separated by centrifugation at 2,000 × g for 5 min. The lower
phase containing the chloroform fraction was transferred to scintillation
vials, dried, and counted for radioactivity to determine the incorpo-
ration of L-[3H]serine into PS.
Live-Cell Imaging. After 24–48 h of transfection, cells on glass coverslips were
subjected to washing with modified Krebs–Ringer buffer (see above), and the
coverslips were mounted to a metal chamber (Atto, Invitrogen). The cells were
observed at room temperature in 1 mL of Krebs–Ringer solution. Confocal
images were obtained with a Zeiss laser confocal microscope (LSM 510, 710, or
780, Carl Zeiss MicroImaging). For TIRF microscopy, the Nikon Ti-E inverted
microscope, equipped with a spinning disk and TIRF acquisition, was used.
BRET Measurement. HEK293-AT1 cells were seeded and transfected as de-
scribed in SI Materials and Methods. Twenty-four hours after transfection,
cells were washed once with modified Krebs–Ringer buffer and incubated
with Krebs–Ringer buffer (50 μL/well) at 37 °C for 30 min before measuring
at room temperature. Coelenterazine h, a luciferase substrate, was then
added in a 40-μL volume (final concentration 5 μM), and the plates were
subjected to base-line measurement for 4 min (1 min/cycle, four cycles). After
base-line measurement, cells were treated with A1 (final concentration
30 nM) added in 10 μL of Krebs–Ringers buffer, and the measurement was
continued for 60 min (1 min/cycle, 60 cycles) in a Tristar2 LB 942 Multimode
Microplate Reader (Berthold Technologies). Emission filters (540/40 nm
and 475/20 nm) were used for Luciferase and Venus fluorescence,
respectively.
Quantitative Real-Time PCR Analysis.HEK293-AT1 cells were seeded onto poly-
lysine–coated 12-well tissue culture plates and transfected with GFP, PSS1
(WT)-GFP, or PSS1(P269S)-GFP plasmid DNA. After 2 d, total RNA was
extracted with an RNeasy mini kit (Qiagen). Following cDNA synthesis, the
analysis was performed as described in SI Materials and Methods.
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